Alutacenoic Acid B

ID: ALA5290280

Chembl Id: CHEMBL5290280

Max Phase: Preclinical

Molecular Formula: C9H12O3

Molecular Weight: 168.19

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCCCCc1cc1=O

Standard InChI:  InChI=1S/C9H12O3/c10-8-6-7(8)4-2-1-3-5-9(11)12/h6H,1-5H2,(H,11,12)

Standard InChI Key:  PILZQFAVBOKECT-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5290280

    ---

Associated Targets(Human)

F13A1 Tchem Coagulation factor XIII (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 168.19Molecular Weight (Monoisotopic): 168.0786AlogP: 1.11#Rotatable Bonds: 6
Polar Surface Area: 54.37Molecular Species: ACIDHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.49CX Basic pKa: CX LogP: 1.81CX LogD: -1.00
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.65Np Likeness Score: 0.81

References

1. Al-Horani RA, Kar S..  (2020)  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.,  200  [PMID:32502864] [10.1016/j.ejmech.2020.112442]

Source